| Clinical data | |
|---|---|
| Trade names | HepaGam B, Nabi-HB, Zutectra, others |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | Intramuscular injection, intravenous |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
  (what is this?) (verify) | |
Hepatitis B immunoglobulin (HBIG) is a human immunoglobulin that is used to prevent the development of hepatitis B[2] and is used for the treatment of acute exposure to HBsAg.[3][4][5]
- ^ "Hepatitis b immune globulin Use During Pregnancy". Drugs.com. 3 August 2020. Retrieved 13 September 2020.
- ^ Zuckerman JN (July 2007). "Review: hepatitis B immune globulin for prevention of hepatitis B infection". Journal of Medical Virology. 79 (7): 919–921. doi:10.1002/jmv.20816. PMID 17516515. S2CID 41095427.
- ^ "HepaGam B (hepatitis b immune globulin intravenous- human injection". DailyMed. U.S. National Library of Medicine. 15 January 2019. Retrieved 14 July 2020.
- ^ "HepaGam B- human hepatitis b virus immune globulin injection". DailyMed. U.S. National Library of Medicine. 16 April 2020. Retrieved 14 July 2020.
- ^ "Nabi-HB (hepatitis b immune globulin- human liquid". DailyMed. U.S. National Library of Medicine. 22 July 2019. Retrieved 14 July 2020.